載入...
Was phenserine a failure or were investigators mislead by methods?
Over 200 Alzheimer’s disease (AD) drug candidates have failed in development, and other neuropsychiatric trials have had their validity compromised. Studies suggest that methodological errors can be a source for these compromises and failures. We gained access to documentation for phenserine, an exp...
Na minha lista:
| 發表在: | Curr Alzheimer Res |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5182048/ https://ncbi.nlm.nih.gov/pubmed/23227991 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|